Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-02-24 @ 12:25 AM
Study NCT ID:
NCT02828020
Status:
COMPLETED
Last Update Posted:
2019-01-03
First Post:
2016-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine
Sponsor:
Allergan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-22
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-14
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-07
First Submit QC Date:
None
Study First Post Date:
2016-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-13
Results First Submit QC Date:
None
Results First Post Date:
2019-01-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-13
Last Update Post Date:
2019-01-03
Last Update Post Date Type:
ACTUAL